vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and Pioneer Bancorp, Inc. (PBFS). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $25.0M, roughly 2.0× Pioneer Bancorp, Inc.). Pioneer Bancorp, Inc. runs the higher net margin — 82.1% vs -71.6%, a 153.7% gap on every dollar of revenue. Over the past eight quarters, Pioneer Bancorp, Inc.'s revenue compounded faster (144.9% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

Pioneer Bancorp, Inc. (MD) is a bank holding company operating as the parent entity of Pioneer Bank. It provides a full suite of retail and commercial banking products and services, including deposit accounts, residential and commercial mortgages, consumer loans, and small business financing, primarily serving individual and corporate customers across local communities in Maryland, U.S.

MRVI vs PBFS — Head-to-Head

Bigger by revenue
MRVI
MRVI
2.0× larger
MRVI
$49.9M
$25.0M
PBFS
Higher net margin
PBFS
PBFS
153.7% more per $
PBFS
82.1%
-71.6%
MRVI
Faster 2-yr revenue CAGR
PBFS
PBFS
Annualised
PBFS
144.9%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
PBFS
PBFS
Revenue
$49.9M
$25.0M
Net Profit
$-35.7M
$3.7M
Gross Margin
25.8%
Operating Margin
-117.9%
21.3%
Net Margin
-71.6%
82.1%
Revenue YoY
-11.8%
Net Profit YoY
-37.7%
EPS (diluted)
$-0.24
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
PBFS
PBFS
Q4 25
$49.9M
$25.0M
Q3 25
$41.6M
$24.0M
Q2 25
$47.4M
$24.4M
Q1 25
$46.9M
$22.8M
Q4 24
$56.6M
Q3 24
$69.0M
$22.0M
Q2 24
$69.4M
$20.9M
Q1 24
$64.2M
$21.6M
Net Profit
MRVI
MRVI
PBFS
PBFS
Q4 25
$-35.7M
$3.7M
Q3 25
$-25.6M
$4.3M
Q2 25
$-39.6M
$6.5M
Q1 25
$-29.9M
$5.8M
Q4 24
$-25.9M
Q3 24
$-97.1M
$6.3M
Q2 24
$-9.8M
$3.9M
Q1 24
$-12.1M
$4.7M
Gross Margin
MRVI
MRVI
PBFS
PBFS
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
MRVI
MRVI
PBFS
PBFS
Q4 25
-117.9%
21.3%
Q3 25
-98.6%
23.4%
Q2 25
-139.8%
33.3%
Q1 25
-104.9%
32.5%
Q4 24
-66.7%
Q3 24
-239.9%
37.2%
Q2 24
-19.4%
24.1%
Q1 24
-29.4%
28.1%
Net Margin
MRVI
MRVI
PBFS
PBFS
Q4 25
-71.6%
82.1%
Q3 25
-61.4%
18.0%
Q2 25
-83.5%
26.4%
Q1 25
-63.9%
25.3%
Q4 24
-45.8%
Q3 24
-140.6%
28.7%
Q2 24
-14.1%
107.4%
Q1 24
-18.8%
21.9%
EPS (diluted)
MRVI
MRVI
PBFS
PBFS
Q4 25
$-0.24
$0.16
Q3 25
$-0.18
$0.18
Q2 25
$-0.27
$0.26
Q1 25
$-0.21
$0.23
Q4 24
$-0.21
Q3 24
$-0.68
$0.25
Q2 24
$-0.07
$0.15
Q1 24
$-0.09
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
PBFS
PBFS
Cash + ST InvestmentsLiquidity on hand
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$212.4M
$323.9M
Total Assets
$770.6M
$2.2B
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
PBFS
PBFS
Q4 25
$216.9M
Q3 25
$243.6M
Q2 25
$269.9M
Q1 25
$285.1M
Q4 24
$322.4M
Q3 24
$578.2M
Q2 24
$573.2M
Q1 24
$561.7M
Total Debt
MRVI
MRVI
PBFS
PBFS
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MRVI
MRVI
PBFS
PBFS
Q4 25
$212.4M
$323.9M
Q3 25
$245.4M
$314.2M
Q2 25
$265.9M
$314.2M
Q1 25
$300.6M
$310.7M
Q4 24
$325.3M
Q3 24
$344.9M
$303.8M
Q2 24
$434.7M
$296.5M
Q1 24
$410.7M
$289.0M
Total Assets
MRVI
MRVI
PBFS
PBFS
Q4 25
$770.6M
$2.2B
Q3 25
$849.2M
$2.2B
Q2 25
$897.0M
$2.1B
Q1 25
$959.8M
$2.1B
Q4 24
$1.0B
Q3 24
$1.3B
$2.0B
Q2 24
$1.4B
Q1 24
$1.4B
$2.0B
Debt / Equity
MRVI
MRVI
PBFS
PBFS
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
PBFS
PBFS
Operating Cash FlowLast quarter
$-22.8M
$11.1M
Free Cash FlowOCF − Capex
$-24.9M
FCF MarginFCF / Revenue
-49.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
2.97×
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
PBFS
PBFS
Q4 25
$-22.8M
$11.1M
Q3 25
$-15.2M
$3.9M
Q2 25
$-10.3M
$5.1M
Q1 25
$-9.4M
$-3.5M
Q4 24
$-14.6M
Q3 24
$13.1M
$1.9M
Q2 24
$17.4M
$9.0M
Q1 24
$-8.5M
$3.3M
Free Cash Flow
MRVI
MRVI
PBFS
PBFS
Q4 25
$-24.9M
Q3 25
$-18.1M
Q2 25
$-13.1M
Q1 25
$-14.6M
Q4 24
$-20.5M
Q3 24
$4.5M
Q2 24
$7.9M
Q1 24
$-14.1M
FCF Margin
MRVI
MRVI
PBFS
PBFS
Q4 25
-49.9%
Q3 25
-43.4%
Q2 25
-27.7%
Q1 25
-31.2%
Q4 24
-36.2%
Q3 24
6.6%
Q2 24
11.4%
Q1 24
-22.0%
Capex Intensity
MRVI
MRVI
PBFS
PBFS
Q4 25
4.2%
Q3 25
7.0%
Q2 25
6.1%
Q1 25
11.2%
Q4 24
10.3%
Q3 24
12.4%
Q2 24
13.8%
Q1 24
8.8%
Cash Conversion
MRVI
MRVI
PBFS
PBFS
Q4 25
2.97×
Q3 25
0.90×
Q2 25
0.78×
Q1 25
-0.61×
Q4 24
Q3 24
0.30×
Q2 24
2.30×
Q1 24
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

PBFS
PBFS

Segment breakdown not available.

Related Comparisons